Prokidney (PROK) EBT Margin (2024 - 2026)

Prokidney (PROK) reported EBT Margin of 18858.85% for Q1 2026, down 261494.0% year-over-year from N/an in Q1 2025, and little changed on a QoQ basis from 18860.89% in Q4 2025.

Prokidney (PROK) has 3 years of EBT Margin data on file, last reported at 18858.85% in Q1 2026.

  • Quarterly EBT Margin fell 261494.0% year-over-year to 18858.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17599.33% (up 3666832.0% YoY) and the FY2025 annual result came in at 16931.47%, up 19876985.0% from the prior year.
  • EBT Margin was little changed at 18858.85% in Q1 2026 per PROK's latest filing, from 18860.89% in the prior quarter.
  • Across five years, EBT Margin topped out at 16243.91% in Q1 2025 and bottomed at 61553.95% in Q4 2024.
  • The 3-year median for EBT Margin is 17600.69% (2025), against an average of 24686.6%.
  • The widest annual swing landed in 2025, when EBT Margin soared 4269306 bps; it then slumped 261494 bps in 2026.
  • Tracing PROK's EBT Margin over 3 years: stood at 61553.95% in 2024, then surged by 69 bps to 18860.89% in 2025, then advanced by 0 bps to 18858.85% in 2026.
  • Per Business Quant, the three latest PROK EBT Margin figures stand at 18858.85% (Q1 2026), 18860.89% (Q4 2025), and 16259.45% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -6.40%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 41.95%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 23.05%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 18.99%
10 Prokidney 259.72 Mn 1.55 Bn - -18,858.85%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18,858.85%
Dec 31, 2025 -18,860.89%
Sep 30, 2025 -16,259.45%
Jun 30, 2025 -16,342.53%
Mar 31, 2025 -16,243.91%
Dec 31, 2024 -61,553.95%